In triple-negative breast cancer cells, both a selective mGluR1 antagonist and silencing with shRNA targeting the gene GRM1 inhibited proliferation associated with apoptosis (143, 213). This evidence concerns the gene GRM1 and triple-negative breast carcinoma.